Protein-losing enteropathy in a child with hypoplastic left heart syndrome after Fontan palliation: a case report

Oxford Medical Case Reports · Published 2026-07-18 · DOI 10.1093/omcr/omag145

Free full text

Authors (3)

Sakeena Saife, Sarah Saife, Momen Zetawi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Saife, S., Saife, S., Zetawi, M. (2026). Protein-losing enteropathy in a child with hypoplastic left heart syndrome after Fontan palliation: a case report. Oxford Medical Case Reports. https://doi.org/10.1093/omcr/omag145

Related articles

• Bronchopulmonary oxalosis revealing pulmonary aspergillosis in an immunocompetent patient: a case report · Oxford Medical Case Reports · 2026 · Same journal
• Celiac disease presenting As recurrent encephalopathy and seizures · Oxford Medical Case Reports · 2026 · Same journal
• Ischemic stroke as the initial presentation of undiagnosed aortic coarctation in an adolescent: a case report · Oxford Medical Case Reports · 2026 · Same journal
• Hemorrhagic shock from a gastrointestinal stromal tumor of the small intestine: an unusual case report · Oxford Medical Case Reports · 2026 · Same journal
• Pediatric pycnodysostosis complicated by severe obstructive sleep apnea: a case report · Oxford Medical Case Reports · 2026 · Same journal
• Retroperitoneal myxoid liposarcoma in a 3.5-year-old Afghan child: a case report and review of the literature · Oxford Medical Case Reports · 2026 · Same journal
• Strength-based physical therapy for anxiety and depressive symptoms in a war-exposed adult: a case report · Oxford Medical Case Reports · 2026 · Same journal
• Pasteurella dagmatis prosthetic valve endocarditis with suspected mycotic aortic aneurysm: a case report · Oxford Medical Case Reports · 2026 · Same journal
• Giant cell myocarditis treated with long-term multi-modal care with multiple mechanical circulatory support: case report · Oxford Medical Case Reports · 2026 · Same journal
• Rosai–Dorfman disease with MAP2K1 mutation: therapeutic response to MEK inhibition after failure of conventional therapy · Oxford Medical Case Reports · 2026 · Same journal